NFKB1 and neoplasm: Treatment of NF-κB inhibitor in PC3-M and C4–2B-M cells blocked the expression of these cytokines and chemokines, suggesting TNF-α-mediated NF-κB activation is essential for PCa cells to alter the tumor environment and promote the advancement of PCa.